Analysis of the efficacy and safety of camrelizumab combined with chemotherapy for cervical cancer treatment
Our analysis showed that the combination of camrelizumab and chemotherapy effectively reduced tumor size and malignancy in cervical cancer treatment, demonstrating robust anti-tumor activity with a favorable safety profile.
Authors
- Jilin Wang (ORCID: https://orcid.org/0000-0001-8385-253X)
- Stephen C. Yang (ORCID: https://orcid.org/0000-0002-2392-1756)
- Xiaoling Mu (ORCID: https://orcid.org/0000-0001-9013-8887)
- Shuang Yang (ORCID: https://orcid.org/0009-0003-3998-1563)
- Bo Yan (ORCID: https://orcid.org/0000-0002-5708-2460)
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Public Health Medical Center (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-21
- DOI
- https://doi.org/10.3389/fonc.2025.1502701
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06